ReviewCancers2026
Biomechanical Forces in Prostate Cancer: Current Insights and Future Directions.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Over the past decade, research in tumor biomechanics has increasingly shown that cancer cells adapt to changing physical microenvironments by rewiring adhesion, cytoskeletal organization, and force-responsive signaling pathways, thereby shaping survival, invasion, and responses to therapy. Prostate cancer (PCa), like other solid tumors, resides in a highly dynamic mechanical milieu molded by extracellular matrix (ECM) remodeling, solid stress, and fluid shear forces. Available evidence generally supports that malignant prostate tissue is stiffer than benign tissue. During metastatic progression, however, the mechanical phenotype of PCa cells appears to undergo context-dependent remodeling. Such mechanical adaptations may help tumor cells withstand the physical challenges associated with circulation, adhesion switching, and colonization, and may intersect with the development of therapy resistance. Here, we synthesize recent advances in PCa biomechanics, highlight the intricate interplay between mechanical cues and tumor biology, and discuss opportunities to incorporate a mechanical perspective into diagnostic and therapeutic strategies. A deeper understanding of these processes may ultimately enable the development of emerging "mechanotherapies" for prostate cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.